Figure 9. Activity assays using recombinant At1g74130 splice variant proteins as exogenous additives and yeast cells.

( A) The typical treatment matrix used in this study is shown. The check marks in the columns indicate the presence of a treatment component. The variant protein tested in Figure 7 is labelled only as L, S, and M in the matrix. The final treatment volume in all cases was 100 µL. ( B) The corresponding plate is shown for each of the treatments depicted in panel A (labelled according to treatment numbers 1 to 9). ( C) Cells (resulting colonies) surviving the different treatments are depicted as Percent Survival in the graph. The treatments are in the same order as presented in panels A and B. The error bars represent standard deviations (minimally n=3).